Zobrazeno 1 - 10
of 72
pro vyhledávání: '"LLOQ, lower limit of quantification"'
Publikováno v:
Journal of Mass Spectrometry and Advances in the Clinical Lab, Vol 23, Iss, Pp 44-49 (2022)
Journal of Mass Spectrometry and Advances in the Clinical Lab
Journal of Mass Spectrometry and Advances in the Clinical Lab
Highlights • Mass spectrometry produces data which can be used to monitor instrument performance. • We describe a tool that parses and visualizes mass spectrometry data. • This toolkit can be applied to increase quality control for a complex LC
Autor:
Zhuowei Liu, Yuxi Wang, Chengjian Zhao, Yang Zhang, Manyu Zhao, Jinliang Yang, Yuqin Yao, Peng Li, Chen Zhengxia, Xiaoxin Chen, Chaofeng Long
Publikováno v:
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, Vol 10, Iss 8, Pp 1453-1475 (2020)
Acta Pharmaceutica Sinica B, Vol 10, Iss 8, Pp 1453-1475 (2020)
Angiokinases, such as vascular endothelial-, fibroblast- and platelet-derived growth factor receptors (VEGFRs, FGFRs and PDGFRs) play crucial roles in tumor angiogenesis. Anti-angiogenesis therapy using multi-angiokinase inhibitor has achieved great
Autor:
Aftab Alam, Abuzer Ali, Mohd Amir, Farhan Jalees Ahmad, Wasim Ahmad, Niyaz Ahmad, Rizwan Ahmad
Publikováno v:
Saudi Journal of Biological Sciences, Vol 27, Iss 1, Pp 500-517 (2020)
Saudi Journal of Biological Sciences
Saudi Journal of Biological Sciences
Graphical abstract
Objective Here, the aim is to improve the bioavailability of Naringenin (NRG) in brain and to establish the highest remedial benefit from a novel anti-ischemic medicine i.e. NRG. Methods A novel Naringenin-loaded-nanoemulsion
Objective Here, the aim is to improve the bioavailability of Naringenin (NRG) in brain and to establish the highest remedial benefit from a novel anti-ischemic medicine i.e. NRG. Methods A novel Naringenin-loaded-nanoemulsion
Autor:
Cecilie L. Bager, Morten A. Karsdal, Bidisha Dasgupta, Carrie Brodmerkel, Mark Curran, Nicholas Willumsen, Jannie M.B. Sand, D.J. Leeming, S Holm Nielsen
Publikováno v:
Biochemistry and Biophysics Reports
Biochemistry and Biophysics Reports, Vol 17, Iss, Pp 38-43 (2019)
Biochemistry and Biophysics Reports, Vol 17, Iss, Pp 38-43 (2019)
Objectives: Lysyl oxidase like 2 (LOXL2) is associated with poor prognosis in idiopathic pulmonary disease (IPF) and cancer. We developed an Enzyme-linked immunosorbent assay (ELISA) targeting the LOXL2 neo-epitope generated through the release of th
Autor:
Philippe, De Smedt, Geert, Leroux-Roels, Corinne, Vandermeulen, Annaelisa, Tasciotti, Gennaro, Di Maro, Marie, Dozot, Daniela, Casula, Margherita, Annaratone, Daniele, Riccucci, Ashwani Kumar, Arora
Publikováno v:
Vaccine: X
Highlights • Older adults with smoking history received two doses of combined NTHi-Mcat vaccine. • We evaluated antibody persistence during 4 years of follow-up after vaccination. • Immune responses against the NTHi protein antigens persisted u
Autor:
Sara Henriksson, John Broberg, Lotta Wik, Ida Grundberg, Martin Lundberg, Erika Assarsson, Niklas Nordberg, Erik Pettersson, Elin Liljeroth, Adam Falck, Johan Björkesten, Christina Westerberg
Publikováno v:
Molecular & Cellular Proteomics : MCP
Understanding the dynamics of the human proteome is crucial for developing biomarkers to be used as measurable indicators for disease severity and progression, patient stratification, and drug development. The Proximity Extension Assay (PEA) is a tec
Autor:
Rafael Esteban, Zobair M. Younossi, Adriana Palom, Luisa Roade, Mar Riveiro-Barciela, Fatema Nader, Maria Buti, Maria Stepanova
Publikováno v:
JHEP Reports
JHEP Reports, Vol 3, Iss 3, Pp 100280-(2021)
JHEP Rep
Scientia
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
JHEP Reports, Vol 3, Iss 3, Pp 100280-(2021)
JHEP Rep
Scientia
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Background & Aims Health-related quality of life (HRQoL) determined by patient-reported outcomes (PROs) is impaired in chronic hepatitis B (CHB) and C patients, but there are no data regarding patients with chronic hepatitis D (CHD). The aim of this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4227ac6bd8a683276690102ac5f584b0
https://ddd.uab.cat/record/241075
https://ddd.uab.cat/record/241075
Publikováno v:
European Journal of Pharmaceutical Sciences
To prepare the way for using the isotopically labelled SABRE hyperpolarized 4,6-d2-nicotinamide as an MRI agent in humans we have performed an in-vivo study to measure its pharmacokinetics in the plasma of healthy rats after intravenous and oral admi
Autor:
Allison C. Provost, Andreas Jeromin, Nikolaos P. Daskalakis, Lauren E. Chaby, Heather Lasseter, Magali Haas
Publikováno v:
Cytokine
Cytokine: X, Vol 2, Iss 2, Pp 100027-(2020)
Cytokine: X, Vol 2, Iss 2, Pp 100027-(2020)
Highlights • Cross-platform comparisons were conducted across five leading immunoassay platforms. • Plasma and serum were obtained from healthy controls and clinical populations. • Analytic parameters included sensitivity, precision, and perfor
Publikováno v:
Molecular Genetics and Metabolism Reports, Vol 22, Iss, Pp-(2020)
Molecular Genetics and Metabolism Reports
Molecular Genetics and Metabolism Reports
Mucopolysaccharidosis III A (MPS IIIA) is an autosomal recessive lysosomal storage disorder caused by deficiency of the enzyme sulfamidase. The disorder results in accumulation of heparan sulfate, lysosomal enlargement and cellular and organ dysfunct